Bora Biologics has named Roger Lias, Ph.D., as Head of Commercial, where he will lead the company’s global commercial activities. Lias will focus on understanding each customer’s program and ...
Adial Pharmaceuticals has appointed David Rubenstein, M.D., Ph.D., as Chief Scientist, where he will lead the Glen Allen, Virginia-based company’s research and scientific strategy. Rubenstein will ...
Georgiamune has signed an exclusive worldwide licensing and collaboration agreement with Italy’s Menarini Group for GIM-621, an experimental oral cancer immunotherapy. Georgiamune is set to receive ...
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s ...
INOVIO Pharmaceuticals, a Plymouth Meeting, Pennsylvania-based biotechnology company developing DNA medicines for HPV-related diseases, cancer, and infectious diseases, has prevailed in its six-year ...
Immunocore (Nasdaq: IMCR), a commercial-stage biotechnology company with U.S. operations in Radnor, Pennsylvania, and Gaithersburg, Maryland, announced on October 15, 2026 that the first patient with ...
Ocugen, a Malvern, Pennsylvania-based biotechnology company developing gene therapies for blindness diseases, has granted Roots Pharmaceutical exclusive rights to its investigational retinitis ...
Arctic Therapeutics (ATx), a clinical-stage biopharmaceutical company with operations in Philadelphia and Reykjavik, Iceland, ...
Life Science Cares Philadelphia has welcomed Gwendolyn Fisher, co-founder and Managing Director of FisherTrent Communications ...
Lillian Chiang, Founder and CEO of Doylestown, Pennsylvania-based Evrys Bio, has received the Timothy M. Block Biotech Impact ...
Iovance Biotherapeutics, a Philadelphia-based commercial biotechnology company developing tumor infiltrating lymphocyte (TIL) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results